See also this year's filing and all EDGAR filings for this company.
PDF Report 0001504735_2012_American_Renal_Holdings_Inc.pdf
Logs
warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'American International Holdings CORP', 'shared_tokens': {'american'}}, {'other_company': 'American Caresource Holdings Inc', 'shared_tokens': {'american'}}, {'other_company': 'American Cryostem Corp', 'shared_tokens': {'american'}}]} |
warning | No stock price available | subcommand.plot | {} |
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001504735, American Renal Holdings Inc
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 539,461,000 |
1 | AssetsNonCurrent | 1,734,000 |
2 | AssetsCurrent | 104,586,000 |
3 | PropertyPlantAndEquipment | 72,416,000 |
4 | remainder_Assets | 4,351,000 |
5 | LongTermLiabilities | 0 |
6 | LiabilitiesCurrent | 62,335,000 |
7 | remainder_Liabilities | 0 |
8 | LaborExpense | 0 |
9 | CostOfGoodsAndServicesSold | 0 |
10 | GeneralAndAdministrativeExpense | 39,309,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 217,036,000 |
13 | DepreciationDepletionAndAmortization | 17,865,000 |
14 | SellingAndMarketingExpense | 0 |
15 | ResearchAndDevelopmentExpense | 0 |
16 | remainder_Expenses | 37,226,000 |
17 | remainder_Revenues | 0 |
18 | remainder_NetIncome | 360,081,000 |
19 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 722,548,000 |
1 | Liabilities | 62,335,000 |
2 | Expenses | 311,436,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 660,213,000 |
5 | NetIncome | 48,645,000 |
6 | ComprehensiveNetIncome | 48,645,000 |
7 | BaseVar | 728,200,000 |
8 | EconomicCapitalRatio | 4.80 |